Skip to content

Searching new Antidote for old deadly celphos poisoning

PILOT STUDY TO ASSESS THE EFFECTIVENESS OF INTRALIPID EMULSION IN REDUCING MORTALITY IN ALUMINUM PHOSPHIDE POISONING - ILINALP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/06/034004
Enrollment
100
Registered
2021-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T608- Toxic effect of other pesticides

Interventions

Intervention1: Intravenous Lipid emulsion: 100 adult patients who present to Medicine emergency with history of aluminum phosphide ingestion will be enrolled in this study. Patients will be randomized

Sponsors

Intra Mural sponsoring body of PGIMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • All the cases with the primary diagnosis of Aluminum phosphide toxicity will be included in the study. • Willing and able to comply with the study procedures and provide written informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: • Patients with a history of any chronic disease (renal and hepatic,cardiac) • Patients refuse to participate in the study. • Aged less than 18 years

Design outcomes

Primary

MeasureTime frame
1. Intravenous lipid emulsion in reducing the mortality in patients of aluminum phosphide poisoningTimepoint: At interval of 2 weeks from admssion

Secondary

MeasureTime frame
Reduction or prevention of organ failure namely cardiac, renal, hepatic, neurological and respiratory â?¢ Prevention of shock â?¢ Reducing length of hospital stay in survivors Timepoint: During current hospitalization at interval of 2 weeks

Countries

India

Contacts

Public ContactMandip singh Bhatia

PGIMER,

bhatiamandip@gmail.com9815253137

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026